Exploration of IMDC model in patients with metastatic renal cell carcinoma using targeted agents: a meta-analysis

Conclusion: In summary, analysis of currently available clinical evidence indicated that IMDC model could be applied to classify patients with metastatic renal cell carcinoma using targeted agents. However, different types of targeted agents and various areas could affect the accuracy of the model. There was also a difference in predicting patients' PFS and OS.
Source: International Braz J Urol - Category: Urology & Nephrology Source Type: research